Easier collection. Lower unsats.

Higher confidence.

1. Collect

2. Drop

3. Send

Assurance that you’ll have fewer unsatisfactory results1,2

Only the BD SurePath™ Liquid-based Pap Test has proven to consistently lower the unsat rate,3,4due to its proprietary cell-enrichment process.1,5,6

Blood is a primary symptom of a patient with cervical cancer.4As little as 50 μL of blood can compromise the ThinPrep® test, with epithelial cell counts dropping to near zero.6


The BD SurePath™ Liquid-based Pap Test removes debris such as blood, mucus and inflammatory cells, aiding in visualization of diagnostically relevant cells—and reducing patient callbacks.1,6

Assurance that you'll have actionable results for patient management

    Only the BD SurePath™ Liquid-based Pap Test provides

    • • Low unsat rates,1,3–5 reducing patient callbacks
    • • Low ASCUS rates,7 minimizing additional tests
    • • A 64.4% increase in HSIL+ detection over conventional Pap2,8
    • • Identification of more precursor lesions, leading to fewer cases of cervical cancer in the follow-up period9

  • For actionable results, be sure with the BD SurePath™ Liquid-based Pap Test.

Change today for total assurance tomorrow.
Be Sure with BD SurePath.

BD is your only trusted partner for the BD SurePathTM Liquid-based Pap Test and the BD OnclarityTM HPV Assay- both approved by the FDA- for HPV primary screening, co-testing and cytology primary with ASCUS reflex.

LEARN MORE

Let's have a conversation



  • HPV, human papillomavirus.
  1. 1. Adegoke O et al. J Womens Health. 2012;21(10):1031-1037.
  2. 2. Kyrigou M et al. Br J Cancer. 2020;123(4):510-517.
  3. 3. Katki HA et al. Lancet Oncol. 2011;12(7):663-672.
  4. 4. Vaughan LM and Malinowski DP. Rev Bras Ginecol Obstet. 2019;41(5):357-359.
  5. 5. de Sanjose S et al. Lancet Oncol. 2010;11:1048-1056.
  6. 6. National Cancer Institute. SEER Cancer Statistics. Available from: https://seer.cancer.gov.
  7. 7. Bruni L et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 22 January 2019.
  8. 8. Elfgren K et al. Am J Obstet Gynecol. 2017;216(3):264.e1-7.
  9. 9. Bodily J et al. Trends Microbiol. 2011;19(1):33-39.